Literature DB >> 17910111

Deep lingual arterial chemoembolization of tongue carcinoma with microcapsuled anticancer drug.

Hong He1, Jian-qi Huang, Fei-yun Ping, Guan-fu Chen, Su-zhan Zhang.   

Abstract

OBJECTIVE: Microcapsule chemoembolism is a promising treatment of tumors. We describe a deep lingual arterial embolization of tongue carcinoma with microcapsuled carboplatinum.
METHODS: Lingual artery cast specimens from cadavers were microscopically examined, and 78 patients with tongue cancer were recruited and treated with the deep lingual arterial embolization therapy.
RESULTS: Microcapsule embolism occurred approximately at the fifth or sixth level of the deep lingual artery branches. The five-year survival rate was 88.5% (69 out of 78), and the ten-year survival rate 52.6% (41 out of 78).
CONCLUSION: The deep lingual arterial embolization of tongue carcinoma with microcapsuled carboplatinum is an effective therapy to treat carcinoma in mid-margin or mid-body of the tongue.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17910111      PMCID: PMC1997222          DOI: 10.1631/jzus.2007.B0704

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  21 in total

1.  Development of small alginate microcapsules for recombinant gene product delivery to the rodent brain.

Authors:  C J D Ross; P L Chang
Journal:  J Biomater Sci Polym Ed       Date:  2002       Impact factor: 3.517

2.  Therapeutic effect of chemoembolization therapy on hepatocellular carcinoma: evaluation with contrast-enhanced power Doppler sonography and contrast-enhanced harmonic imaging.

Authors:  Jose M Esteban; J Gil
Journal:  Acad Radiol       Date:  2002-08       Impact factor: 3.173

3.  Arterial chemoembolization with mitomycin C microcapsules in the treatment of primary or secondary carcinoma of the kidney, liver, bone and intrapelvic organs.

Authors:  T Kato; R Nemoto; H Mori; M Takahashi; M Harada
Journal:  Cancer       Date:  1981-08-01       Impact factor: 6.860

4.  Hepatic artery chemoembolization for hepatocellular carcinoma in patients listed for liver transplantation.

Authors:  Paul H Hayashi; Michael Ludkowski; Lisa M Forman; Michael Osgood; Stephen Johnson; Marcelo Kugelmas; James F Trotter; Thomas Bak; Michael Wachs; Igal Kam; Janette Durham; Gregory T Everson
Journal:  Am J Transplant       Date:  2004-05       Impact factor: 8.086

5.  The role of transarterial embolization in the treatment of renal cell carcinoma.

Authors:  N P Munro; S Woodhams; J D Nawrocki; M S Fletcher; P J Thomas
Journal:  BJU Int       Date:  2003-08       Impact factor: 5.588

6.  Transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma invading the portal veins: therapeutic effects and prognostic factors.

Authors:  Junji Uraki; Koichiro Yamakado; Atsuhiro Nakatsuka; Kan Takeda
Journal:  Eur J Radiol       Date:  2004-07       Impact factor: 3.528

7.  Expression of vascular endothelial growth factor and prognosis of oral squamous cell carcinoma.

Authors:  Masataka Uehara; Kazuo Sano; Hisazumi Ikeda; Joji Sekine; Akihiko Irie; Tomohisa Yokota; Takayoshi Tobita; Seigo Ohba; Tsugio Inokuchi
Journal:  Oral Oncol       Date:  2004-03       Impact factor: 5.337

8.  Role of additional angiography and chemoembolization in patients with hepatocellular carcinoma who achieved complete necrosis following transarterial chemoembolization.

Authors:  Myoung Kuk Jang; Han Chu Lee; In Sook Kim; Young-Suk Lim; Young-Hwa Chung; Yung Sang Lee; Kyu-Bo Sung; Hyun-Ki Yoon; Gi-Young Ko; Ah Young Kim; Dong Jin Suh
Journal:  J Gastroenterol Hepatol       Date:  2004-09       Impact factor: 4.029

9.  Anterior tongue cancer: age is not a predictor of outcome and should not alter treatment.

Authors:  Michael J Veness; Gary J Morgan; Yasoda Sathiyaseelan; Val Gebski
Journal:  ANZ J Surg       Date:  2003-11       Impact factor: 1.872

Review 10.  Treatment of metastatic carcinoid tumors using multimodality therapy of octreotide acetate, intra-arterial chemotherapy, and hepatic arterial chemoembolization.

Authors:  D S Diaco; H Hajarizadeh; C R Mueller; W S Fletcher; R F Pommier; E A Woltering
Journal:  Am J Surg       Date:  1995-05       Impact factor: 2.565

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.